We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Clinical Laboratory Automation Solutions Help Eliminate Manual Processes

By LabMedica International staff writers
Posted on 19 Oct 2009
Three new clinical laboratory automation solutions help eliminate manual processes performed by laboratory personnel.

The manual production of diagnostic test results requires time and labor. More...
Automating certain steps in this process can improve efficiency and quality of operations, thus reducing the time it takes to produce the test results. The three automation systems were introduced by Siemens Healthcare Diagnostics (Deerfield, IL, USA).

The Advia Centaur XP immunoassay system can connect to the VersaCell system, an automation system offering advanced sample management and sorting capabilities. This maximizes the number of tests run on one workcell and improves the efficiency of operations.

When there are high test volumes, the VersaCell system can be used to connect Advia Centaur XP systems to Immulite immunoassay systems to access a wide range of routine and specialty immunoassays. For mid-to-high levels of test volumes, an Advia Centaur XP system can connect to an Advia 1800 chemistry system to gain access to a broader menu of immunochemistry and chemistry tests.

A decapper module was introduced to pair with the Advia LabCell and the Advia WorkCell automation systems. The removal of test tube caps reduces manual labor connected with processing patient samples by automating.

Clearance for the connection of the Advia Centaur XP system to the StreamLab analytical workcell was given by the U.S. Food and Drug Administration (FDA; Silver Spring, MD, USA). The combination of the high-speed immunoassay system and a scalable, open-architecture automation system increases laboratories' efficiencies.

Related Links:

Siemens Healthcare Diagnostics
U.S Food and Drug Administration



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.